Receipt of the 21-gene recurrence score assay (RS) impacts breast cancer treatment and health care costs.
The incidence of febrile neutropenia was significantly higher among patients who received pegfilgrastim prophylaxis on the same day.
Use of estrogen with progestin increases the risk of estrogen receptor (ER)-positive breast cancer in African American women.
Women who have ovarian cancer often develop ascites, a buildup of fluids in the abdomen. Researchers have found that ascites can be reduced with minimal side effects through inhibition of the colony-stimulating-factor-1 receptor (CSF1R).
Affordable Care Act (ACA) Impacts Stage at Diagnosis and Fertility-Sparing Treatment in Young Women With Cervical Cancer
Both the stage of cervical cancer at diagnosis and the receipt of fertility-sparing treatment among young women age 21 to 25 years, but not among women age 26 to 34 years, is associated with the Affordable Care Act Dependent Coverage Expansion provision.
A new test is better at detecting aggressive prostate cancer than measuring PSA levels. The new test discovers aggressive cancer earlier and reduces the number of false positive tests and unnecessary biopsies.
An international team of scientists has mapped out the genetic trajectories taken by melanoma as it evolves from early skin lesions to malignant skin cancer.
Childhood cancer survivors are at heightened risk of a wide range of autoimmune diseases. Diabetes and Addison's disease make up almost half of the excess cases, according to the findings.
To test thyroid malignancy, many biomarkers are tested separately to confirm cancer. However, new research shows that the tests used to measure 2 major biomarkers in the diagnosis of thyroid cancer may be inaccurate.
New Model for Breast Cancer Risk in Hispanic Women Is the First to be Based Exclusively on Data From Hispanic Women
The first breast cancer risk-prediction model based entirely on data from Hispanic women, including whether a woman was born in or outside the United States, provides a more accurate assessment of Hispanic women's risk of developing breast cancer.
New and better drugs to treat diseases such as advanced breast cancer will have little effect on improving patient outcomes if a country does not have good health care structures in place.
International Experts Call for Investigations Into Long-Term Management Options for Select Patients With Advanced Breast Cancer
International experts have called for a clinical trial to investigate the best ways for identifying and treating a small but important group of patients with advanced breast cancer who can survive for long periods without their disease progressing.
Patients With Advanced Breast Cancer Address an International Conference About Misleading Disease-Specific Messages
Patients with advanced breast cancer spoke out about the damaging messages some organizations issue about advanced breast cancer. They need to be identified and educated to change the way they talk about the disease.
The more children a woman has or whether she has undergone tubal ligation lowers her risk of different types of ovarian cancer to different levels, according to new research presented at the 2015 NCRI Cancer Conference.
A widely available, inexpensive blood test can predict outcomes and guide treatment in pancreatic cancer; however, only 1 in 5 US patients with the disease have the blood test.
- Existing Drug May Limit Recurrence and Metastasis of Glioblastoma Multiforme
- Blood Test Indicates Breast Cancer Tumors Developed Resistance to Hormone Treatment
- Breakthrough Advance Announced in International Blood Cancer Drug Trial
- Yoga Provides Mental, Emotional, and Physical Benefits for Patients With Cancer
- New Blood Test Improves Screening for Prostate Cancer
- Breastfeeding Associated With A Reduced Risk of Aggressive Breast Cancer
- Hospitals Should Enact Bereavement Programs, Researchers Urge
- Physical Activity Communications Should be Part of Oncology Care Clinic Visits With Patients
- Communication Practices of Many US Physicians May Be Discouraging HPV Vaccination
- Chemo, Tamoxifen May Increase VTE Risk Among Patients With Breast Cancer
- Use of Genomic Testing in Breast Cancer Has Greater Impact on Treatment, Costs
- Timing Matters for Pegfilgrastim Administration
- Estrogen Plus Progestin Use Increases ER+ Breast Cancer Risk in African American Women
- CSF1R Inhibition May Ease Debilitating Adverse Event of Ovarian Cancer
- Affordable Care Act (ACA) Impacts Stage at Diagnosis and Fertility-Sparing Treatment in Young Women With Cervical Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|